194 filings
Page 7 of 10
8-K
ygx46
28 May 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
4izlca5k
21 May 20
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the Digital EAACI Annual Congress 2020
8:06am
8-K
ein7ua 8qx5dlsv
11 May 20
Allakos Reports First Quarter 2020 Financial Results
8:05am
8-K
bdm67n51 45
4 May 20
Other Events
8:06am
8-K
xrn0ontgb5e4c8e xu4
21 Apr 20
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2020 DDW Annual Meeting
8:05am
8-K
vijjnlmpskbn2suay1
13 Apr 20
Entry into a Material Definitive Agreement
4:05pm
8-K
g8yf249ozu9fym
24 Mar 20
Other Events
4:56pm
8-K
ic6528mdrui4o
24 Mar 20
Allakos Announces the Initiation of Antolimab (AK002) Clinical Studies
4:06pm
S-8
w4w91l6xg4n lvu
25 Feb 20
Registration of securities for employees
5:07pm
8-K
08tqjgvq
25 Feb 20
Allakos Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:06pm
8-K
mxz boz9c3h
24 Feb 20
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2020 AAAAI Annual Meeting
8:05am
8-K
688h0c5
23 Jan 20
Other Events
8:00am
8-K
ncbupquk
9 Dec 19
Entry into a Material Definitive Agreement
4:06pm
8-K
qf0rdo5v1w5zr 6z7om
12 Nov 19
Allakos Reports Third Quarter 2019 Financial Results
4:05pm
8-K
iw78 whx5zpma3
29 Oct 19
Regulation FD Disclosure
9:00am
8-K
8z364
28 Oct 19
Other Events
9:05am